Caricamento...
Effect of Liver Disease on Hepatic Transporter Expression and Function
Liver disease can alter the disposition of xenobiotics and endogenous substances. Regulatory agencies such as the Food and Drug Administration (FDA) and the European Medicines Evaluation Agency (EMEA) recommend, if possible, studying the effect of liver disease on drugs under development to guide sp...
Salvato in:
| Pubblicato in: | J Pharm Sci |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5614511/ https://ncbi.nlm.nih.gov/pubmed/28465155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xphs.2017.04.053 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|